文献速递妇科生殖医学

蛋白激酶CK2通过基质细胞SDF-1-CXCR4依赖方式参与雌激素介导的内皮祖细胞归巢至子宫内膜异位病灶

Protein kinase CK2 participates in estrogen-mediated endothelial progenitor cell homing to endometriotic lesions through stromal cells in a stromal cell-derived factor-1- CXCR4-dependent manner.
PubMed 文献 · Fertil Steril · 2020-01-01

本研究为实验室研究,采用BALB/c小鼠子宫内膜异位症模型及人子宫内膜基质细胞,探讨蛋白激酶CK2在雌激素招募内皮祖细胞(EPC)中的作用。结果显示CK2通过激活AKT/mTOR通路上调基质细胞SDF-1表达与分泌,以SDF-1-CXCR4依赖方式促进EPC迁移和招募,CK2抑制剂CX-4945可抑制该过程,提示CK2可能为治疗靶点。

要点

  • CK2过表达或雌激素预处理的人子宫内膜基质细胞条件培养基显著增强EPC迁移和招募。
  • CK2通过激活AKT/mTOR通路上调基质细胞SDF-1表达与分泌。
  • CXCR4特异性抑制剂AMD3100可完全逆转CK2增强的EPC迁移。

核心结论

  • 蛋白激酶CK2通过基质细胞以SDF-1-CXCR4依赖方式参与雌激素介导的EPC归巢至子宫内膜异位病灶,可能成为治疗靶点。

研究设计与样本

  • 实验室研究,使用BALB/c小鼠,通过同种异体小鼠子宫内膜移植至背侧皮肤褶皱腔构建子宫内膜异位症模型。
  • 干预包括人子宫内膜基质细胞暴露于雌激素和CK2抑制剂CX-4945,以及转染蛋白激酶CK2载体的基质细胞(HESC-CK2)。
  • 小鼠每日腹腔注射50 mg/kg大黄素,或每周皮下注射100 μg/kg雌激素一次。

主要发现

  • 稳定转染CK2载体或雌激素预处理的人子宫内膜基质细胞条件培养基显著增强EPC迁移和招募。
  • CX-4945处理的人子宫内膜基质细胞条件培养基抑制EPC迁移和活力。
  • CK2过表达通过激活AKT/mTOR通路显著上调基质细胞SDF-1表达和分泌。
  • AMD3100完全逆转CK2增强的EPC迁移。

临床怎么用

  • CK2可能作为抑制子宫内膜异位症血管生成的潜在治疗靶点,但尚未进入临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the possible mechanism of protein kinase CK2, which participates in estrogen recruitment of endothelial progenitor cells (EPCs), and its role in the angiogenesis of endometriosis lesions. DESIGN: Laboratory study. SETTING: University. ANIMAL(S): BALB/c mice. INTERVENTION(S): Exposure of human endometrial stromal cells (HESCs) to estrogen and CK2 inhibitor CX-4945 and endometrial stromal cells transfected with the protein kinase CK2 vector (HESC-CK2). Endometriosis models were induced by allogeneic mice transplantation of the endometrium into dorsal skinfold chambers. The mice received an IP injection of 50 mg/kg emodin per day or were treated with 100 μg/kg estrogen by SC injection once a week. MAIN OUTCOME MEASURE(S): The concentration of cytokines in cells was measured with ELISA. The migration of EPCs was examined using the scratch assay method and Transwell, a capillary tube-formation assay to determine EPC tube-forming capacity, and protein and mRNA expression with Western blot and polymerase chain reaction analyses, respectively. RESULT(S): Protein kinase CK2 participates in estrogen-mediated EPC homing to endometriotic lesions through stromal cells in a stromal cell-derived factor-1 (SDF-1)-CXCR4-dependent manner. Conditioned medium from endometrial stromal cells that were stably transfected with the protein kinase CK2 vector (HESC-CK2) or pretreated with estrogen significantly enhanced the migration and recruitment of EPCs. In contrast, conditioned medium from HESCs that were treated with CX-4945, a selective inhibitor of CK2, inhibited the mobility and viability of EPCs. Furthermore, CK2 overexpression significantly upregulated SDF-1 expression and secretion in endometrial stromal cells by activating the AKT/mTOR pathway. Moreover, treatment with the SDF-1 receptor CXCR4-specific inhibitor AMD3100 completely reversed the CK2-enhanced migration of EPCs. CONCLUSION(S): This study demonstrates that CK2 participates in estrogen-mediated EPC homing to endometriotic lesions through stromal cells in an SDF-1-CXCR4-dependent manner and may be a therapeutic target.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Zhao R, Feng D, Zhuang G, et al. Protein kinase CK2 participates in estrogen-mediated endothelial progenitor cell homing to endometriotic lesions through stromal cells in a stromal cell-derived factor-1- CXCR4-dependent manner. Fertil Steril. 2020. PMID: 32386617. doi:10.1016/j.fertnstert.2019.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。